Titan Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TTNP and other ETFs, options, and stocks.

About TTNP

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. 

CEO
David Elliot Lazar
CEODavid Elliot Lazar
Employees
11
Employees11
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
1992
Founded1992
Employees
11
Employees11

TTNP Key Statistics

Market cap
15.51M
Market cap15.51M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
59.57K
Average volume59.57K
High today
$1.11
High today$1.11
Low today
$1.04
Low today$1.04
Open price
$1.06
Open price$1.06
Volume
11.91K
Volume11.91K
52 Week high
$2.03
52 Week high$2.03
52 Week low
$0.3496
52 Week low$0.3496

TTNP Earnings

-$0.96
-$0.64
-$0.32
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, After Hours
ActualExpected Nov 14, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.